Novaquest Capital Management, L.L.C 13F annual report
Novaquest Capital Management, L.L.C is an investment fund managing more than $54.3 million ran by John Jr.. There are currently 2 companies in Mr. Jr.’s portfolio. The largest investments include Myovant Sciences and Revance Therapeutics, together worth $54.3 million.
$54.3 million Assets Under Management (AUM)
As of 6th November 2020, Novaquest Capital Management, L.L.C’s top holding is 3,474,645 shares of Myovant Sciences currently worth over $48.8 million and making up 90.0% of the portfolio value.Relative to the number of outstanding shares of Myovant Sciences, Novaquest Capital Management, L.L.C owns more than approximately 0.1% of the company.In addition, the fund holds 216,038 shares of Revance Therapeutics worth $5.43 million, whose value grew 37.6% in the past six months.
Currently, Novaquest Capital Management, L.L.C's portfolio is worth at least $54.3 million. The total portfolio value may be much higher due to cash assets that are not publicly disclosed such as fixed income, real estate, or cash equivalents.
Careers at Novaquest Capital Management, L.L.C
The Novaquest Capital Management, L.L.C office and employees reside in Raleigh, North Carolina. According to the last 13-F report filed with the SEC, John Jr. serves as the Manager at Novaquest Capital Management, L.L.C.